Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-04-17 | Phillip L Gomez began serving as Chief Executive Officer on October 13, 2016 and was appointed as a director on December 6, 2016. Prior to joining SIGA, Dr. Gomez was a Principal in the Pharma & Life Sciences Management Consulting Practice at PricewaterhouseCoopers LLP (“PwC”) since 2011. |
| 2018-04-18 | Phillip L Gomez began serving as Chief Executive Officer on October 13, 2016 and was appointed as a director on December 6, 2016. Prior to joining SIGA, Dr. Gomez was a Principal in the Pharma & Life Sciences Management Consulting Practice at PricewaterhouseCoopers LLP (PwC) since 2011. At PwC, and at PRTM Management Consultants (PRTM), where he was a Director from 2007-2011 prior its acquisition by PwC, Dr. Gomez led the team that focused on the development and execution of business strategies for leading pharmaceutical companies, governmental agencies, academic medical centers, and foundations with respect to product development and manufacturing of pharmaceutical products. |
| 2019-04-29 | Phillip L. Gomez began serving as Chief Executive Officer on October 13, 2016 and was appointed as a director on December 6, 2016. ... Director Compensation ... Phillip L. Gomez, Ph.D.(4) ... Chief Executive Officer; refer to Summary Compensation Table for applicable details. ... Fees Earned ($): — ... Total ($): —. |
| 2020-04-28 | Phillip L Gomez began serving as Chief Executive Officer on October 13, 2016 and was appointed as a director on December 6, 2016. ... Director Compensation ... Phillip L. Gomez, Ph.D. ... Total ($) — |
Data sourced from SEC filings. Last updated: 2026-02-08